Advanced search
Publication Cover
Emerging Microbes & Infections Volume 11, 2022 - Issue 1
Submit an article Journal homepage
8,331
Views
26
CrossRef citations to date
0
Altmetric
Coronaviruses

Resistance of SARS-CoV-2 Omicron variant to convalescent and CoronaVac vaccine plasma

Yingdan Wanga Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS) and Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Public Health Clinical Center, School of Basic Medical Sciences, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Yunping Maa Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS) and Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Public Health Clinical Center, School of Basic Medical Sciences, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Yan Xub The Biomedical Translational Research Institute, Faculty of Medical Science, Jinan University, Guangzhou, People’s Republic of China;c Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine, Zhuhai People’s Hospital Affiliated with Jinan University, Jinan University, Zhuhai, People’s Republic of ChinaView further author information
,
Jiangyan Liua Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS) and Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Public Health Clinical Center, School of Basic Medical Sciences, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Xiang Lia Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS) and Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Public Health Clinical Center, School of Basic Medical Sciences, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Yuyuan Chenb The Biomedical Translational Research Institute, Faculty of Medical Science, Jinan University, Guangzhou, People’s Republic of China;c Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine, Zhuhai People’s Hospital Affiliated with Jinan University, Jinan University, Zhuhai, People’s Republic of ChinaView further author information
,
Yan Chenb The Biomedical Translational Research Institute, Faculty of Medical Science, Jinan University, Guangzhou, People’s Republic of China;c Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine, Zhuhai People’s Hospital Affiliated with Jinan University, Jinan University, Zhuhai, People’s Republic of ChinaView further author information
,
Jun Xied Department of Joint Orthopedics, Guanghua Hospital Affiliated to Shanghai, University of Traditional Chinese Medicine, Shanghai, People’s Republic of ChinaView further author information
,
Lianbo Xiaod Department of Joint Orthopedics, Guanghua Hospital Affiliated to Shanghai, University of Traditional Chinese Medicine, Shanghai, People’s Republic of ChinaView further author information
,
Zheng Xiange Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, People’s Republic of ChinaCorrespondence[email protected]
View further author information
,
Fan Wua Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS) and Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Public Health Clinical Center, School of Basic Medical Sciences, Fudan University, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
View further author information
&
Jinghe Huanga Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS) and Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Public Health Clinical Center, School of Basic Medical Sciences, Fudan University, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Pages 425-428 | Received 23 Dec 2021, Accepted 05 Jan 2022, Published online: 28 Jan 2022

References

  • WHO. WHO Coronavirus (COVID-19) Dashboard. 2021. Available from: https://covid19.who.int/.
  • Tregoning JS, Flight KE, Higham SL, et al. Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape. Nat Rev Immunol. 2021;21:626–636. DOI:10.1038/s41577-021-00592-1.
  • WHO. Classification of Omicron (B.1.1.529): SARS-CoV-2 variant of concern. 2021. Available from: https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern.
  • CDC. Science brief: Omicron (B.1.1.529) variant. 2021. Available from: https://www.cdc.gov/coronavirus/2019-ncov/science/science-briefs/scientific-brief-omicron-variant.html.
  • Wu F, Liu M, Wang A, et al. Evaluating the association of clinical characteristics with neutralizing antibody levels in patients who have recovered from mild COVID-19 in Shanghai, china. JAMA Intern Med. 2020;180(10):1356–1362. DOI:10.1001/jamainternmed.2020.4616.
  • Cao YR, Wang J, Jian F, et al. B. 1.1. 529 escapes the majority of SARS-CoV-2 neutralizing antibodies of diverse epitopes. bioRxiv. 2021. DOI:10.1101/2021.12.07.470392
  • Cele S, Jackson L, Khan K, et al. SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection. medRxiv. 2021. DOI:10.1101/2021.12.08.21267417.
  • Schmidt F, Muecksch F, Weisblum Y, et al. Plasma neutralization properties of the SARS-CoV-2 Omicron variant. medRxiv. 2021. DOI: 10.1101/2021.12.12.21267646
  • Wilhelm A, Widera M, Grikscheit K, et al. Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies. medRxiv. 2021. DOI:10.1101/2021.12.07.21267432
  • Zhang L, Li Q, Liang Z, et al. The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron. Emerg Microbes Infect. 2022;11(1):1–5.
  • Levin EG, Lustig Y, Cohen C, et al. Waning immune humoral response to BNT162b2 COVID vaccine over 6 months. N Engl J Med. 2021;385:e84.
  • Barda N, Dagan N, Cohen C, et al. Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study. Lancet. 2021;398:10316.
  • Ai J, Zhang H, Zhang Y, et al. Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost. Emerg Microbes Infect. 2021. DOI:10.1080/22221751.2021.2022440
  • Uriu K, Kimura I, Shirakawa K, et al. Neutralization of the SARS-CoV-2 Mu variant by convalescent and vaccine serum. N Engl J Med. 2021;385:2397–2399. DOI:10.1056/NEJMc2114706.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.